Blennow K - Search Results

1

Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability.

Therriault J, Janelidze S, Benedet AL, Ashton NJ, Arranz Martínez J, Gonzalez-Escalante A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM, Hyung Hong C, Roh HW, Contador J, Puig Pijoan A, Algeciras-Schimnich A, Vemuri P, Graff-Radford J, Lowe VJ, Karikari TK, Jonaitis E, Brum W, Tissot C, Servaes S, Rahmouni N, Macedo AC, Stevenson J, Fernandez-Arias J, Wang YT, Woo MS, Friese MA, Jia WL, Dumurgier J, Hourregue C, Cognat E, Ferreira PL, Vitali P, Johnson S, Pascoal TA, Gauthier S, Lleó A, Paquet C, Petersen RC, Salmon D, Mattsson-Carlgren N, Palmqvist S, Stomrud E, Galasko D, Son SJ, Zetterberg H, Fortea J, Suárez-Calvet M, Jack CR Jr, Blennow K, Hansson O, Rosa-Neto P. Therriault J, et al. Among authors: blennow k. Nat Aging. 2024 Nov;4(11):1529-1537. doi: 10.1038/s43587-024-00731-y. Epub 2024 Nov 12. Nat Aging. 2024. PMID: 39533113 Free PMC article.

2

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L. Blennow K, et al. Aging (Milano). 1992 Dec;4(4):301-6. Aging (Milano). 1992. PMID: 1294245

3

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L. Blennow K, et al. Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r. Neurobiol Aging. 1992. PMID: 1371850

4

Clinical heterogeneity of probable Alzheimer's disease.

Blennow K, Wallin A. Blennow K, et al. J Geriatr Psychiatry Neurol. 1992 Apr-Jun;5(2):106-13. doi: 10.1177/002383099200500208. J Geriatr Psychiatry Neurol. 1992. PMID: 1590911

5

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

6

Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG. Blennow K, et al. Aging (Milano). 1990 Dec;2(4):395-401. Aging (Milano). 1990. PMID: 2094379

7

Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.

Blennow K, Wallin A, Fredman P, Gottfries CG, Karlsson I, Svennerholm L. Blennow K, et al. Eur Neuropsychopharmacol. 1990 Nov;1(1):79-81. doi: 10.1016/0924-977x(90)90017-5. Eur Neuropsychopharmacol. 1990. PMID: 2136219

8

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.

Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blennow K, et al. Acta Neurol Scand. 1990 Apr;81(4):323-6. doi: 10.1111/j.1600-0404.1990.tb01563.x. Acta Neurol Scand. 1990. PMID: 2360400

9

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Blennow K, Hesse C, Fredman P. Blennow K, et al. Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032. Neuroreport. 1994. PMID: 7696597

10

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,198 results

Search Page

Filters